SANUWAVE Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 09/30/25 | FY 06/30/25 | FY 03/31/25 | FY 12/31/24 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $44.1M | — | — | — | $32.6M |
| Cost of revenue | $10.1M | — | — | — | $8.1M |
| Gross profit | $34.0M | — | — | — | $24.6M |
| Research and development | $1.4M | — | — | — | $673,000 |
| Operating expenses | $29.0M | — | — | — | $20.7M |
| Operating income | $4.9M | — | — | — | $3.8M |
| Pretax income | $11.9M | — | — | — | -$33.1M |
| Income tax expense | $86,000 | — | — | — | $27,000 |
| Net income | $11.8M | — | — | — | -$33.1M |
| Balance Sheet | |||||
| Cash and equivalents | $12.0M | — | — | — | $10.2M |
| Current assets | $24.6M | — | — | — | $18.4M |
| Total assets | $37.3M | — | — | — | $30.1M |
| Current liabilities | $17.8M | $24.0M | $50.4M | $50.8M | $45.4M |
| Total liabilities | $35.7M | $43.2M | $51.8M | $51.7M | $45.9M |
| Total debt | $22.2M | — | — | — | — |
| Stockholders' equity | $1.6M | -$7.6M | -$18.8M | -$20.8M | -$15.8M |
| Cash Flow Statement | |||||
| Cash from operations | $3.9M | — | — | — | $2.5M |
| Depreciation and amortization | $974,000 | — | — | — | $788,000 |
| Stock-based compensation | $4.8M | — | — | — | $1.5M |
| Capital expenditure | $1.9M | — | — | — | $490,000 |
| Free cash flow | $1.9M | — | — | — | $2.0M |
| Impairments | $196,000 | — | — | — | $0 |
Shares outstanding 8.6M · Free float 74.1%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.